These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11129108)

  • 1. An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment.
    Hassin-Baer S; Korczyn AD; Giladi N
    J Neural Transm (Vienna); 2000; 107(10):1187-9. PubMed ID: 11129108
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of buspirone for treatment of cerebellar ataxia. An open-label study.
    Lou JS; Goldfarb L; McShane L; Gatev P; Hallett M
    Arch Neurol; 1995 Oct; 52(10):982-8. PubMed ID: 7575226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Buspirone chlorhydrate in the treatment of cerebellar ataxia].
    Andrade-Filho AS; Passos-Almeida J; Andrade-Souza VM; Sena-Pereira LR
    Rev Neurol; 2002 Aug 16-31; 35(4):301-5. PubMed ID: 12235556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P; Xie J; Adeleine P
    Lancet; 1996 Sep; 348(9029):759. PubMed ID: 8806320
    [No Abstract]   [Full Text] [Related]  

  • 5. Amantadine treatment in cerebellar ataxia.
    Sareen D; Kumar V
    J Assoc Physicians India; 2001 Mar; 49():382. PubMed ID: 11291986
    [No Abstract]   [Full Text] [Related]  

  • 6. Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy.
    Trouillas P; Xie J; Adeleine P; Michel D; Vighetto A; Honnorat J; Dumas R; Nighoghossian N; Laurent B
    Arch Neurol; 1997 Jun; 54(6):749-52. PubMed ID: 9193210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of buspirone, a serotonergic 5-HT-1A agonist in cerebellar ataxia: a pilot study. Preliminary communication].
    Trouillas P; Xie J; Getenet JC; Adeleine P; Nighoghossian N; Honnorat J; Riche G; Derex L
    Rev Neurol (Paris); 1995 Dec; 151(12):708-13. PubMed ID: 8787101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of buspirone for the treatment of cerebellar ataxia in an older individual.
    Holroyd-Leduc JM; Liu BA; Maki BE; Zecevic A; Herrmann N; Black SE
    Can J Clin Pharmacol; 2005; 12(3):e218-21. PubMed ID: 16278493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of spinocerebellar ataxia with buspirone.
    Assadi M; Campellone JV; Janson CG; Veloski JJ; Schwartzman RJ; Leone P
    J Neurol Sci; 2007 Sep; 260(1-2):143-6. PubMed ID: 17512011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Buspirone in the treatment of cerebellar ataxia].
    Svetel M; Vojvodić N; Filipović SR; Dragasević N; Sternić N; Kostić VS
    Srp Arh Celok Lek; 1999; 127(9-10):312-5. PubMed ID: 10649900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment.
    Perlman S; Boltshauser E
    Handb Clin Neurol; 2018; 155():371-377. PubMed ID: 29891072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB; Shealy CN; Mercier DA
    Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of cerebellar ataxia with 5-HT1A agonist.
    Takei A; Hamada T; Yabe I; Sasaki H
    Cerebellum; 2005; 4(3):211-5. PubMed ID: 16147954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amantadine and dexetimide in the treatment of parkinsonism].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
    [No Abstract]   [Full Text] [Related]  

  • 15. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of cerebellar ataxia.
    Jones TM; Shaw JD; Sullivan K; Zesiewicz TA
    Neurodegener Dis Manag; 2014; 4(5):379-92. PubMed ID: 25405651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
    Castaigne P; Laplane D; Dordain G
    Nouv Presse Med; 1972 Feb; 1(8):533-6. PubMed ID: 5012351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hereditary cerebellar ataxia: clinical analysis of 18 cases].
    Wang ML
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Jun; 19(3):155-7. PubMed ID: 3757631
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lecithin therapy of hereditary ataxia].
    Trizio M; Pozio G; Margari L; Massagli A; Serlenga L
    Riv Patol Nerv Ment; 1983; 104(2):49-59. PubMed ID: 6679921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of olivopontocerebellar atrophy.
    Goetz CG; Tanner CM; Klawans HL
    Adv Neurol; 1984; 41():143-8. PubMed ID: 6496225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.